144 related articles for article (PubMed ID: 29141461)
1. Development of magnetic anionic liposome/atelocollagen complexes for efficient magnetic drug targeting.
Kono Y; Nakai T; Taguchi H; Fujita T
Drug Deliv; 2017 Nov; 24(1):1740-1749. PubMed ID: 29141461
[TBL] [Abstract][Full Text] [Related]
2. [Preparation of Magnetized Mesenchymal Stem Cells Using Magnetic Liposomes to Enhance Their Retention in Targeted Tissue -Evaluation of Retention and Anti-inflammatory Efficiency in Skeletal Muscle].
Kono Y
Yakugaku Zasshi; 2022; 142(11):1145-1151. PubMed ID: 36328443
[TBL] [Abstract][Full Text] [Related]
3. Enhanced macrophage delivery to the colon using magnetic lipoplexes with a magnetic field.
Kono Y; Gogatsubo S; Ohba T; Fujita T
Drug Deliv; 2019 Dec; 26(1):935-943. PubMed ID: 31530198
[TBL] [Abstract][Full Text] [Related]
4. Efficient Liposome Loading onto Surface of Mesenchymal Stem Cells via Electrostatic Interactions for Tumor-Targeted Drug Delivery.
Kono Y; Kamino R; Hirabayashi S; Kishimoto T; Kanbara H; Danjo S; Hosokawa M; Ogawara KI
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831094
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of magnetic cationic liposome in gene delivery.
Zheng X; Lu J; Deng L; Xiong Y; Chen J
Int J Pharm; 2009 Jan; 366(1-2):211-7. PubMed ID: 18848871
[TBL] [Abstract][Full Text] [Related]
6. Cell-penetrating corosolic acid liposome as a functional carrier for delivering chemotherapeutic drugs.
Li X; Widjaya AS; Liu J; Liu X; Long Z; Jiang Y
Acta Biomater; 2020 Apr; 106():301-313. PubMed ID: 32081779
[TBL] [Abstract][Full Text] [Related]
7. Characterization of 9-nitrocamptothecin-in-cyclodextrin-in-liposomes modified with transferrin for the treating of tumor.
Chen J; Lu S; Gu W; Peng P; Dong J; Xu F; Yang X; Xiong Z; Yang X
Int J Pharm; 2015 Jul; 490(1-2):219-28. PubMed ID: 26004006
[TBL] [Abstract][Full Text] [Related]
8. Enhanced plasmid DNA delivery using anionic LPDII by listeriolysin O incorporation.
Lorenzi GL; Lee KD
J Gene Med; 2005 Aug; 7(8):1077-85. PubMed ID: 15776501
[TBL] [Abstract][Full Text] [Related]
9. Biocompatible anionic polyelectrolyte for improved liposome based gene transfection.
Chen M; Zeng Z; Qu X; Tang Y; Long Q; Feng X
Int J Pharm; 2015 Jul; 490(1-2):173-9. PubMed ID: 26004001
[TBL] [Abstract][Full Text] [Related]
10. Galactose-modified cationic liposomes as a liver-targeting delivery system for small interfering RNA.
Sonoke S; Ueda T; Fujiwara K; Kuwabara K; Yano J
Biol Pharm Bull; 2011; 34(8):1338-42. PubMed ID: 21804229
[TBL] [Abstract][Full Text] [Related]
11. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
[TBL] [Abstract][Full Text] [Related]
12. Fate of cationic liposomes and their complex with oligonucleotide in vivo.
Litzinger DC; Brown JM; Wala I; Kaufman SA; Van GY; Farrell CL; Collins D
Biochim Biophys Acta; 1996 Jun; 1281(2):139-49. PubMed ID: 8664312
[TBL] [Abstract][Full Text] [Related]
13. The drug loading, cytotoxicty and tumor vascular targeting characteristics of magnetite in magnetic drug targeting.
Dandamudi S; Campbell RB
Biomaterials; 2007 Nov; 28(31):4673-83. PubMed ID: 17688940
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol anchored arabinogalactan for asialoglycoprotein receptor targeting: synthesis, characterization, and proof of concept of hepatospecific delivery.
Pathak PO; Nagarsenker MS; Barhate CR; Padhye SG; Dhawan VV; Bhattacharyya D; Viswanathan CL; Steiniger F; Fahr A
Carbohydr Res; 2015 May; 408():33-43. PubMed ID: 25841057
[TBL] [Abstract][Full Text] [Related]
15. Suppression of Phagocytic Activity Leads to the Efficient Surface Modification of Macrophages with Liposomes for Developing a Biomimetic Drug Delivery System.
Kono Y; Uesugi N; Saegusa M; Onishi K; Hosokawa M; Ogawara KI
Biol Pharm Bull; 2023; 46(9):1347-1351. PubMed ID: 37661414
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of magnetic cationic liposomes for targeting tumor microvasculature.
Dandamudi S; Campbell RB
Biochim Biophys Acta; 2007 Mar; 1768(3):427-38. PubMed ID: 17258172
[TBL] [Abstract][Full Text] [Related]
17. Influence of Physicochemical Properties and PEG Modification of Magnetic Liposomes on Their Interaction with Intestinal Epithelial Caco-2 Cells.
Kono Y; Jinzai H; Kotera Y; Fujita T
Biol Pharm Bull; 2017 Dec; 40(12):2166-2174. PubMed ID: 28966298
[TBL] [Abstract][Full Text] [Related]
18. Chitooligosaccharides Modified Reduction-Sensitive Liposomes: Enhanced Cytoplasmic Drug Delivery and Osteosarcomas-Tumor Inhibition in Animal Models.
Yin X; Chi Y; Guo C; Feng S; Liu J; Sun K; Wu Z
Pharm Res; 2017 Oct; 34(10):2172-2184. PubMed ID: 28726003
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and biodistribution of cationic liposomes and their DNA complexes.
Ishiwata H; Suzuki N; Ando S; Kikuchi H; Kitagawa T
J Control Release; 2000 Oct; 69(1):139-48. PubMed ID: 11018552
[TBL] [Abstract][Full Text] [Related]
20. Hydroxycamptothecin liposomes based on thermal and magnetic dual-responsive system: preparation, in vitro and in vivo antitumor activity, microdialysis-based tumor pharmacokinetics.
Zhu HM; Gu JH; Xie Y; Xie B; Ling JJ
J Drug Target; 2018 Apr; 26(4):345-356. PubMed ID: 28920483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
